NAGLAZYME (BioMarin Pharmaceutical Inc.)
Welcome to the PulseAid listing for the NAGLAZYME drug offered from BioMarin Pharmaceutical Inc.. This alpha-Glucosidases [Chemical/Ingredient],Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | BioMarin Pharmaceutical Inc. |
| NON-PROPRIETARY NAME: | galsulfase |
| SUBSTANCE NAME: | GALSULFASE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | alpha-Glucosidases [Chemical/Ingredient],Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | SOLUTION |
| MARKETING CATEGORY NAME: | BLA |
| START MARKETING DATE: | 2005-06-09 |
| END MARKETING DATE: | 0000-00-00 |
NAGLAZYME HUMAN PRESCRIPTION DRUG Details:
| Item Description | NAGLAZYME from BioMarin Pharmaceutical Inc. |
| LABELER NAME: | BioMarin Pharmaceutical Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 5(mg/5mL) |
| START MARKETING DATE: | 2005-06-09 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 68135-020_02065670-6928-4671-8bf5-e51a9ebf0699 |
| PRODUCT NDC: | 68135-020 |
| APPLICATION NUMBER: | BLA125117 |
Other GALSULFASE Pharmaceutical Manufacturers / Labelers:
